摘要
随着生活水平的提高,非酒精性脂肪性肝病(NAFLD)发病率逐年升高并且趋于年轻化,但其具体发病机制尚未明确。巨噬细胞作为参与NAFLD发病的重要细胞之一,一直广受关注。针对肝脏巨噬细胞的来源及分类、巨噬细胞在NAFLD肝脏炎症中的作用和其活化的机制、靶向巨噬细胞药物进行阐述,旨在为临床治疗NAFLD提供参考。
With the improvement of living standard,the incidence rate of nonalcoholic fatty liver disease(NAFLD)is gradually increasing year by year and its age of onset tends to become younger,but its pathogenesis remains unclear.Macrophages are important cells involved in the pathogenesis of NAFLD and have attracted great attention.This article elaborates on the origin and classification of liver macrophages,the role of macrophages in liver inflammation and related activation mechanism,and the drugs targeting macrophages,in order to provide a reference for the clinical treatment of NAFLD.
作者
罗雨欣
郭金波
张晓岚
LUO Yuxin;GUO Jinbo;ZHANG Xiaolan(Department of Gastroenterology,The Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2020年第3期680-683,共4页
Journal of Clinical Hepatology
基金
国家自然科学基金资助项目(81900522)。
关键词
非酒精性脂肪性肝病
巨噬细胞
治疗学
non-alcoholic fatty liver disease
macrophages
therapeutics